BAP Consensus Guidelines

Document Title Size Published
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology
Topic: Adult ADHD
Co-Authors: Blanca Bolea-Alamañac, David J Nutt, Marios Adamou, Phillip Asherson, Stephen Bazire, David Coghill, David Heal, Ulrich Müller, John Nash, Paramalah Santosh, Kapil Sayal, Edmund Sonuga- Barke and Susan J Young for the Consensus Group
Show: full details
397 Kb 2014
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology
Topic: Anxiety Disorder
Co-Authors: David S Baldwin, Ian M Anderson, David J Nutt, Christer Allgulander, Borwin Bandelow, Johan A den Boer, David M Christmas, Simon Davies, Naomi Fineberg, Nicky Lidbetter, Andrea Malizia, Paul McCrone, Daniel Nabarro, Catherine O’Neill, Jan Scott, Nic van der Wee and Hans-Ulrich Wittchen
Show: full details
683 Kb 2014
Benzodiazepines: Risks and benefits. A reconsideration
Topic: Benzodiazepines
Co-Authors: David S Baldwin, Katherine Aitchison, Alan Bateson, H Valerie Curran, Simon Davies, Brian Leonard, David J Nutt, David N Stephens and Sue Wilson
Show: full details
726 Kb 2013
Evidence based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from the British Association for Psychopharmacology
Topic: Addiction
Co-Authors: AR Lingford-Hughes, S Welch, L Peters and DJ Nutt
Show: full details
1,134 Kb 2012
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
Topic: Insomnia
Co-Authors: SJ Wilson, DJ Nutt, C Alford, SV Argyropoulos, DS Baldwin, AN Bateson, TC Britton, C Crowe, D-J Dijk, CA Espie, P Gringras, G Hajak, C Idzikowski, AD Krystal, JR Nash, H Selsick, AL Sharpley and AG Wade
Show: full details
752 Kb 2010
Clinical practice with anti-dementia drugs: a revised (second) consensus statement from British Association for Psychopharmacology
Topic: Anti-Dementia Drugs
Co-Authors: A Burns and J O’Brien on behalf of the BAP Dementia Consensus Group
Show: full details
466 Kb 2010
Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
Topic: Schizophrenia
Co-Authors: Thomas R E Barnes and the Consensus Group
Show: full details
422 Kb 2010
Evidence-based Guidelines for Treating Bipolar Disorder
Topic: Bipolar Disorder
Co-Authors: GM Goodwin on behalf of the Consensus Group
Show: full details
645 Kb 2009
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines
Topic: Antidepressants
Co-Authors: IM Anderson, IN Ferrier, RC Baldwin, PJ Cowen, L Howard, G Lewis, K Matthews, RH McAllister-Williams, RC Peveler, J Scott, A Tylee
Show: full details
491 Kb 2008

Latest News

Subscribe to the News Feed rss feed

  1. BAP Summer Meeting 2014 - Tuesday Digest by Suzi Gage
    on 23rd July 2014

    Suzi Gage attended the post-doctoral symposium and the award winner’s oral sessions on Tuesday. Here are her thoughts.

  2. BAP Summer Meeting 2014 - Tuesday Digest by Meg Fluharty
    on 23rd July 2014

    On Tuesday, Meg Fluharty attended the ‘Chicken and Egg’ morning session, and ‘Understanding Cognition and Emotion’

  3. BAP Summer Meeting 2014 - Tuesday Digest by Michael Dalili
    on 23rd July 2014

    Michael Dalili attended the symposium on genetic pathways in psychosis, and the short orals session on developing depression

See more news